| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |